My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 30

    1.

    Efficacy and Tolerability of Ziprasidone vs. Olanzapine in Naive First-Episode Schizophrenia: A 6-Week, Randomized, Open-Label, Flexible-Dose Study.

    Li YM, Zhao JP, Ou JJ, Wu RR.

    Pharmacopsychiatry. 2012 Jan 30. [Epub ahead of print]

    PMID:
    22290206
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Adjunctive Mood Stabilizer and Benzodiazepine Use in Older Asian Patients with Schizophrenia, 2001-2009.

    Xiang YT, Dickerson F, Kreyenbuhl J, Ungvari GS, Wang CY, Si TM, Lee EH, He YL, Chiu HF, Yang SY, Chong MY, Tan CH, Kua EH, Fujii S, Sim K, Yong MK, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Shinfuku N.

    Pharmacopsychiatry. 2012 Jan 30. [Epub ahead of print]

    PMID:
    22290203
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Are Ratings on the Positive and Negative Syndrome Scale for Schizophrenia Biased by Personality Traits?

    Huber CG, Hoppe A, Agorastos A, Andresen B, Naber D, Schroeder K.

    Pharmacopsychiatry. 2012 Jan 30. [Epub ahead of print]

    PMID:
    22290202
    [PubMed - as supplied by publisher]

    Related citations

    4.

    Psychotropic Drug Treatment, Clinical Characteristics and Cognitive Processing Speed in Patients with Schizophrenia: Results from the ELAN Study.

    Frasch K, Weiser P, Becker T, Längle G, Steinert T, Niederreiner C, Pfiffner C, Jäger S, Bayer W, Eschweiler GW, Kilian R.

    Pharmacopsychiatry. 2011 Dec 15. [Epub ahead of print]

    PMID:
    22174026
    [PubMed - as supplied by publisher]

    Related citations

    5.

    How Psychotropic Polypharmacy in Schizophrenia Begins: A Longitudinal Perspective.

    Shinfuku M, Uchida H, Tsutsumi C, Suzuki T, Watanabe K, Kimura Y, Tsutsumi Y, Ishii K, Imasaka Y, Mimura M, Kapur S.

    Pharmacopsychiatry. 2011 Dec 15. [Epub ahead of print]

    PMID:
    22174025
    [PubMed - as supplied by publisher]

    Related citations

    6.

    Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.

    Chen JJ, Chan HY, Chen CH, Gau SS, Hwu HG.

    Pharmacopsychiatry. 2012 Mar;45(2):64-71. Epub 2011 Nov 15.

    PMID:
    22086749
    [PubMed - in process]

    Related citations

    7.

    Report of a case of steroid-induced psychosis and inappropriate sexual behaviour in an adolescent.

    Demir T, Karacetin G, Dogangun B, Kocabasoglu N.

    Pharmacopsychiatry. 2012 Mar;45(2):77-9. Epub 2011 Nov 15.

    PMID:
    22086740
    [PubMed - in process]

    Related citations

    8.

    Error occurred: cannot get document summary

    PMID:
    22095218

    9.

    Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).

    Xiang YT, Wang CY, Si TM, Lee EH, He YL, Ungvari GS, Chiu HF, Yang SY, Chong MY, Tan CH, Kua EH, Fujii S, Sim K, Yong KH, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Shinfuku N.

    Pharmacopsychiatry. 2012 Jan;45(1):7-12. Epub 2011 Oct 11.

    PMID:
    21989602
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial.

    Mautone A, Scarone S; all investigators.

    Pharmacopsychiatry. 2011 Jul;44(5):173-8. Epub 2011 Jul 12.

    PMID:
    21751127
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Body mass index increase, serum leptin, adiponectin, neuropeptide Y and lipid levels during treatment with olanzapine and haloperidol.

    Raposo NR, Ferreira AS, Gattaz WF.

    Pharmacopsychiatry. 2011 Jul;44(5):169-72. Epub 2011 Jul 5.

    PMID:
    21732272
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Increased brain membrane fluidity in schizophrenia.

    Eckert GP, Schaeffer EL, Schmitt A, Maras A, Gattaz WF.

    Pharmacopsychiatry. 2011 Jun;44(4):161-2. Epub 2011 Jun 27.

    PMID:
    21710408
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.

    Molina JD, Toledo-Romero F, López-Rodríguez E, Amorin-Díaz M, Lerma-Carrillo I, López-Muñoz F.

    Pharmacopsychiatry. 2011 Jun;44(4):142-7. Epub 2011 Jun 27.

    PMID:
    21710404
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Weight changes and their associations with demographic and clinical characteristics in risperidone maintenance treatment for schizophrenia.

    Xiang YT, Wang CY, Ungvari GS, Kreyenbuhl JA, Chiu HF, Lai KY, Lee EH, Bo QJ, Dixon LB.

    Pharmacopsychiatry. 2011 Jun;44(4):135-41. Epub 2011 Jun 27.

    PMID:
    21710403
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Schizophrenia trial participation: perceived inclusion barriers and beliefs about antipsychotics.

    Ghio L, Natta W, Barbato A, Marcenaro M, Gotelli S, Jones PB, Parabiaghi A.

    Pharmacopsychiatry. 2011 Jun;44(4):123-8. Epub 2011 Jun 27.

    PMID:
    21710401
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.

    Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, Bibulowicz D, Simonienko K, Walecki J.

    Pharmacopsychiatry. 2011 Jun;44(4):148-57. Epub 2011 Jun 27.

    PMID:
    21710405
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being.

    Liemburg E, Aleman A, Bous J, Hollander K, Knegtering H.

    Pharmacopsychiatry. 2011 May;44(3):109-13. Epub 2011 Mar 22.

    PMID:
    21432752
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009.

    Xiang YT, Wang CY, Si TM, Lee EH, He YL, Ungvari GS, Chiu HF, Yang SY, Chong MY, Tan CH, Kua EH, Fujii S, Sim K, Yong KH, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Shinfuku N.

    Pharmacopsychiatry. 2011 May;44(3):114-8. Epub 2011 Apr 13.

    PMID:
    21491361
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Short-term prospective comparison of prepulse inhibition between schizophrenic patients and healthy controls.

    Preuss UW, Zimmermann J, Watzke S, Langosch J, Siafarikas N, Wong JW, Hamm A, Weike A.

    Pharmacopsychiatry. 2011 May;44(3):102-8. Epub 2011 Mar 22.

    PMID:
    21432751
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Clozapine plasma level monitoring for prediction of rehospitalization schizophrenic outpatients.

    Stieffenhofer V, Saglam H, Schmidtmann I, Silver H, Hiemke C, Konrad A.

    Pharmacopsychiatry. 2011 Mar;44(2):55-9. Epub 2011 Jan 4.

    PMID:
    21207352
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk